Why the study?
Most studies scaling cardiorespiratory fitness by body mass may inflate its association with cardiometabolic health in overweight and obese individuals.
Does the method of scaling cardiorespiratory fitness affect its association with cardiometabolic risk factors in overweight and obese adults with metabolic syndrome?
Does the method of scaling cardiorespiratory fitness affect its association with cardiometabolic risk factors in overweight and obese adults with metabolic syndrome?
Using body mass to scale cardiorespiratory fitness may confound its association with cardiometabolic risk in overweight and obese adults, suggesting alternative scaling methods should be considered.
Body mass scaling of CRF was associated with cardiometabolic markers; hypothesis-generating for optimal scaling methods in obese adults.
BACKGROUND: Cardiorespiratory fitness (CRF) has been inversely associated with insulin resistance and clustering of cardiometabolic risk factors among overweight and obese individuals. However, most previous studies have scaled CRF by body mass (BM) possibly inflating the association between CRF and cardiometabolic health. We investigated the associations of peak oxygen uptake (V̇O2peak) and peak power output (Wpeak) scaled either by BM-1, fat free mass (FFM-1), or by allometric methods with individual cardiometabolic risk factors and clustering of cardiometabolic risk factors in 55 overweight or obese adults with metabolic syndrome.METHODS: V̇O2peak and Wpeak were assessed by a maximal cycle ergometer exercise test. FFM was measured by air displacement plethysmograph and glucose, insulin, HbA1c, triglycerides, and total, LDL, and HDL cholesterol from fasting blood samples. HOMA-IR and metabolic syndrome score (MetS) were computed.RESULTS: V̇O2peak and Wpeak scaled by BM-1 were inversely associated with insulin (β=-0.404 to -0.372, 95% CI: -0.704 to -0.048), HOMA-IR (β=-0.442 to -0.440, 95% CI: -0.762 to -0.117), and MetS (β=-0.474 to -0.463, 95% CI: -0.798 to -0.127). Other measures of CRF were not associated with cardiometabolic risk factors.CONCLUSIONS: Our results suggest that using BM-1 as a scaling factor confounds the associations between CRF and cardiometabolic risk in overweight/obese adults with the metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: